1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ep 045 in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ep 045) | Trials (ep 045) | Recent Studies (post-2010) (ep 045) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 12 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, RA; Jones, RL; Wilson, NH | 1 |
| Bushfield, M; MacIntyre, DE; MacMillan, LJ; McNicol, A; Pollock, WK; Shaw, AM | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ep 045
| Article | Year |
|---|---|
Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha.
Topics: Adenosine Diphosphate; Aspirin; Cyclic AMP; Cyclic GMP; Dinoprost; Humans; Platelet Activating Factor; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins F; Prostaglandins H; Prostaglandins, Synthetic; Thrombin | 1985 |
Endogenous and pharmacological mechanisms for the regulation of human platelet cytosolic free Ca2+.
Topics: Aminoquinolines; Blood Platelets; Calcium; Calcium Channel Blockers; Cytosol; Egtazic Acid; Fluorescent Dyes; Homeostasis; Humans; Kinetics; Phosphatidylinositols; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Thromboxanes | 1985 |